20-36889299-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_080628.3(TLDC2):c.561C>A(p.Ser187Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00458 in 1,614,178 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0030 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0047 ( 30 hom. )
Consequence
TLDC2
NM_080628.3 missense
NM_080628.3 missense
Scores
5
6
8
Clinical Significance
Conservation
PhyloP100: 0.208
Genes affected
TLDC2 (HGNC:16112): (TBC/LysM-associated domain containing 2) Predicted to be involved in response to oxidative stress. Predicted to act upstream of or within negative regulation of oxidative stress-induced neuron death. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06825146).
BP6
Variant 20-36889299-C-A is Benign according to our data. Variant chr20-36889299-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 2652303.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 30 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TLDC2 | NM_080628.3 | c.561C>A | p.Ser187Arg | missense_variant | 6/7 | ENST00000217320.8 | |
TLDC2 | NM_001304783.1 | c.465C>A | p.Ser155Arg | missense_variant | 5/6 | ||
TLDC2 | XM_017027674.2 | c.273C>A | p.Ser91Arg | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TLDC2 | ENST00000217320.8 | c.561C>A | p.Ser187Arg | missense_variant | 6/7 | 1 | NM_080628.3 | P1 | |
TLDC2 | ENST00000602922.5 | c.561C>A | p.Ser187Arg | missense_variant | 6/6 | 1 | P1 | ||
TLDC2 | ENST00000436941.1 | c.74+1771C>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00303 AC: 461AN: 152202Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
461
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00271 AC: 680AN: 251310Hom.: 2 AF XY: 0.00264 AC XY: 359AN XY: 135834
GnomAD3 exomes
AF:
AC:
680
AN:
251310
Hom.:
AF XY:
AC XY:
359
AN XY:
135834
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00475 AC: 6938AN: 1461858Hom.: 30 Cov.: 30 AF XY: 0.00468 AC XY: 3406AN XY: 727228
GnomAD4 exome
AF:
AC:
6938
AN:
1461858
Hom.:
Cov.:
30
AF XY:
AC XY:
3406
AN XY:
727228
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00303 AC: 461AN: 152320Hom.: 1 Cov.: 32 AF XY: 0.00274 AC XY: 204AN XY: 74482
GnomAD4 genome
AF:
AC:
461
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
204
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
20
ALSPAC
AF:
AC:
26
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
43
ExAC
AF:
AC:
341
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | TLDC2: BP4, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;H
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Pathogenic
.;D
REVEL
Uncertain
Sift
Pathogenic
.;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Gain of solvent accessibility (P = 0.0365);Gain of solvent accessibility (P = 0.0365);
MVP
MPC
0.35
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at